地塞米松的故事及其如何成为神经外科最广泛使用的药物之一
本文回顾地塞米松在神经外科兴起的历史,并讨论其在脑肿瘤中的应用及新兴神经肿瘤免疫治疗背景下的使用。1958年Glen E. Arth合成地塞米松用于治疗类风湿关节炎,神经外科住院医师Joseph Galicich将其用于开颅肿瘤切除患者,观察到轻瘫改善、中线移位消退和死亡率下降,倡导临床试验后该药成为神经外科主要用药。随着免疫治疗发展,地塞米松的免疫抑制作用成为不利效应,需研究在现代神经肿瘤治疗背景下治疗症状性水肿的方法。
要点
- 1958年Glen E. Arth合成地塞米松用于治疗类风湿关节炎。
- Joseph Galicich将地塞米松用于开颅肿瘤切除患者,观察到轻瘫改善、中线移位消退和死亡率下降。
- 地塞米松作为脑水肿标准药物已超过60年,但免疫抑制作用在免疫治疗时代成为不利效应。
核心结论
- 地塞米松作为脑水肿标准药物已超过60年,但随着免疫治疗的出现,需研究在现代神经肿瘤治疗背景下治疗症状性水肿的方法。
研究设计与样本
- 本文为历史回顾性文章,回顾地塞米松在神经外科的兴起历史并讨论其在脑肿瘤中的应用。
主要发现
- 1958年Glen E. Arth为治疗类风湿关节炎合成了可的松的16-α-甲基化类似物(地塞米松)。
- 时任神经外科住院医师Joseph Galicich将这一风湿病药物应用于神经外科,给开颅肿瘤切除患者用药后观察到轻瘫改善、中线移位消退和死亡率下降。
- Galicich倡导临床试验,该药成为神经外科的主要用药。
- 随着神经肿瘤治疗发展至包括免疫治疗,地塞米松的免疫抑制作用正成为不利效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dexamethasone, a long-acting potent glucocorticoid, is one of the most widely used medications in neurosurgery. In this paper, the authors recount the history of dexamethasone's rise in neurosurgery and discuss its use in brain tumors in the context of emerging neuro-oncological immunotherapies. In 1958, Glen E. Arth synthesized a 16-alpha-methylated analog of cortisone (dexamethasone) for treatment of rheumatoid arthritis. Joseph Galicich, a neurosurgery resident at the time, applied the rheumatological drug to neurosurgery. He gave doses to patients who had undergone craniotomy for tumor removal and saw their paresis improve, midline shift resolve, and mortality rates decrease. He advocated for clinical trials and the drug became a mainstay in neurosurgery. As neuro-oncological treatments evolve to include immunotherapy, the immunosuppressive effects of dexamethasone are becoming an unwanted effect. The question then becomes: how does one treat the patient's symptoms if the only drug that has been used throughout history may become a detriment to their oncological treatment? Since its discovery, dexamethasone has maintained an impressive staying power in the field, acting as a standard drug for cerebral edema for more than 60 years. However, with the advent of immunotherapy, research is warranted to evaluate ways of treating symptomatic edema in the context of modern neuro-oncological therapies.
引用
- Vazquez S, Gold J, Spirollari E, et al. The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery. J Neurosurg. 2023. PMID: 38000066. doi:10.3171/2023.9.JNS231099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。